Healthcare
Neurocrine Biosciences (NBIX)
Neurocrine Biosciences stock analysis and opportunity scoring
$138.94
↓ -0.39%
Neurocrine Biosciences (NBIX) at a glance
Neurocrine Biosciences (NBIX) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
NBIX last traded at $152.57 as of 2026-09-26.
MKD Intelligence assigns NBIX a composite opportunity score of 37 out of 100, indicating cautious conditions across trend, momentum and volume factors.
The risk score for NBIX is 38 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$158.35
Low
$138.94
Period
Sep 24 - Aug 21 (24d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 26
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.